TY - JOUR
T1 - Patient-centered care for left ventricular assist device therapy
T2 - Current challenges and future directions
AU - Breathett, Khadijah
AU - Allen, Larry A.
AU - Ambardekar, Amrut V.
N1 - Publisher Copyright:
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016
Y1 - 2016
N2 - Purpose of review Discuss the current status and obstacles that need to be overcome in the future to provide patient-centered care with left ventricular assist device (LVAD) therapy. Recent findings LVADs offer both longer survival and improvements in quality of life for carefully selected patients with inotrope-dependent heart failure. Yet, this technology does not come without significant risk of adverse effects and burdens. Recent observational data comparing LVAD with medical therapy in ambulatory, noninotrope-dependent patients with advanced heart failure suggest that survival may be similar and changes in quality of life may depend on baseline status. As both LVAD technology and medical therapy continue to evolve, there are many unanswered questions regarding the benefits, risks, and burdens of LVAD therapies in less severe heart failure populations. Summary Further research is needed to ensure the optimal delivery of LVAD therapy, including improved patient selection, implantation timing, device type, and decision support.
AB - Purpose of review Discuss the current status and obstacles that need to be overcome in the future to provide patient-centered care with left ventricular assist device (LVAD) therapy. Recent findings LVADs offer both longer survival and improvements in quality of life for carefully selected patients with inotrope-dependent heart failure. Yet, this technology does not come without significant risk of adverse effects and burdens. Recent observational data comparing LVAD with medical therapy in ambulatory, noninotrope-dependent patients with advanced heart failure suggest that survival may be similar and changes in quality of life may depend on baseline status. As both LVAD technology and medical therapy continue to evolve, there are many unanswered questions regarding the benefits, risks, and burdens of LVAD therapies in less severe heart failure populations. Summary Further research is needed to ensure the optimal delivery of LVAD therapy, including improved patient selection, implantation timing, device type, and decision support.
KW - Decision-making
KW - Heart failure
KW - Left ventricular assist device
KW - Mechanical circulatory support
UR - http://www.scopus.com/inward/record.url?scp=84958818425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958818425&partnerID=8YFLogxK
U2 - 10.1097/HCO.0000000000000279
DO - 10.1097/HCO.0000000000000279
M3 - Review article
C2 - 26890085
AN - SCOPUS:84958818425
SN - 0268-4705
VL - 31
SP - 313
EP - 320
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
IS - 3
ER -